Icatibant acetate

This classification denotes an adrenergic beta-antagonist C59H89N19O13S.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 325O8467XK, chemically known as l-arginine, d-arginyl-l-arginyl-l-prolyl-trans-4-hydroxy-l-prolylglycyl-3-(2-thienyl)-l-alanyl-l-seryl-d-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-l-(2.alpha.,3a.beta.,7a.beta.)-octahydro-1h-indole-2-carbonyl-, acetate (salt), but more generally known as icatibant acetate, which bears US NIH Compound Identifier 6918172. European Medicines Agency schedules Icatibant acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29718. Most nations, for tariff and trade purposes, schedule icatibant acetate under HS 29349990 and SITC 51579. As of Q4 2014, ICATIBANT ACETATE remains US FDA's Preferred Term for this commodity. Icatibant acetate bears US NLM identifiers UMLS ID C0082926 and NCI Concept Code C98884. SMILES: CC(=O)O.C1CCC2C(C1)C[C@@H](N(C2)C(=O)[C@H](CO)NC(=O)[C@H](CC3CCCS3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)N)O)C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)O.